Intellipharmaceutics International Inc. (IPCI)

[fabius]

My personal idea about the Focalin FDA mess, is that IPCI decided not to sue for "political" reasons: since they were and they still are positively and actively speaking with FDA on Rexista, it would probably be wrong for a small cap like IPCI to go against them (even if I think there would be room for legal actions).

I share your points on the complexity of the Agreement; I think the schema that Angelo has already outlined a couple of times on this board is what they should work on.

Multiple steps, with upfront payments based on deadlines, royalties based on volumes, and options on the future abuse deterrant patents and NDAs.
If Rexista is the elephant in the room, PODRAS is the mammut.

What seems to be really interesting for us is that IPCI is developing a technological Platform, which should attract some Big Pharma, taking us to a likely take over in 3-5yrs from now....at which price I really don't know.